8HQ3

KL1 in complex with CRM1-Ran-RanBP1

8HQ3 の概要

• エントリーDOI: 10.2210/pdb8hq3/pdb
• 分子名称: GTP-binding nuclear protein Ran, methyl (3~{S},5~{R},6~{E},8~{Z},10~{R},12~{E},14~{E},16~{R})-3,16-bis(azanyl)-8,10,12-trimethyl-16-[(2~{S},4~{R},5~{S},6~{S})-5-methyl-4-oxidanyl-6-[(~{E})-prop-1-enyl]oxan-2-yl]-5-oxidanyl-hexadeca-6,8,12,14-tetraenoate, YRB1 isoform 1, ... (11 entities in total)
• 機能のキーワード: nuclear export inhibitor, transport protein
• 由来する生物種: Homo sapiens (human); 詳細
• タンパク質・核酸の鎖数: 3
• 化学式量合計: 159185.42

構造登録者

Sun, Q.,Jian, L. (登録日: 2022-12-13, 公開日: 2023-10-25)

主引用文献

Jian, L.,Zscherp, R.,Beutling, U.,Shen, X.,Xu, S.,Zhang, X.,Bronstrup, M.,Klahn, P.,Sun, Q.
Discovery of Aminoratjadone Derivatives as Potent Noncovalent CRM1 Inhibitors.
J.Med.Chem., 66:11940-11950, 2023

PubMed Abstract: Cancer cells frequently utilize elevated nuclear export to escape tumor suppression and gain proliferative advantage. Chromosome Region Maintenance 1 (CRM1/XPO1) mediates macromolecule nuclear export and plays an important role in tumorigenesis and progression. The clinical approval of its covalent inhibitor KPT-330 (Selinexor) validates the feasibility of targeting CRM1 to treat cancers. Here, we synthesized four aminoratjadone derivatives and found that two of them, and , are noncovalent CRM1 inhibitors. The two compounds underwent spontaneous hydrolysis in aqueous buffers, and the resulting products were more active against CRM1. High-resolution crystal structures revealed the CRM1-binding mode of these compounds and explained the observed structure-activity relationships. In cells, and localized CRM1 in the nuclear periphery and led to depletion of nuclear CRM1, thereby inhibiting the nuclear export and growth of colorectal cancer cells at submicromolar concentrations. This work lays the foundation for further development of aminoratjadone-based noncovalent CRM1 inhibitors.

PubMed: 37595020
DOI: 10.1021/acs.jmedchem.3c00549

実験手法

X-RAY DIFFRACTION (2.1 Å)